(Erstwhile SBI Pharma Fund) Table of Contents To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. SBI Healthcare Opportunities Fund is a Equity - Sectoral fund launched on 31 Dec 04. It is a fund with High risk and has given a Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on Historical performance (Yearly) on absolute basis SBI Healthcare Opportunities Fund - G
Scheme Objective
CAGR return of 15.1% since its launch. Ranked 34 in Sectoral category. Return for 2020 was 65.8% , 2019 was -0.5% and 2018 was -9.9% . NAV as on 18 Jun 21 ₹223.825 ↓ -0.87 (-0.39 %) Net Assets (AUM) as on 30 Apr 2021 ₹1,748 Cr. Launch Date 31 Dec 2004 Category Equity - Sectoral Rating ☆☆ Type Open Ended Fund Risk High AMC SBI Funds Management Private Limited Alpha Ratio 5.0 Expense Ratio 2.37 % Sharpe Ratio 2.621 Information Ratio 0.06 Benchmark Not Available Min Investment ₹5,000 Min SIP Investment ₹500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) NAV Price Chart
Returns
Annual Compounded Returns
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 18 Jun 21 Duration Returns 1 Month 1.6% 3 Month 20.9% 6 Month 15.1% 1 Year 53.4% 3 Year 24% 5 Year 11% 10 Year 15 Year Since launch 15.1% Historical Annual Returns
Year Returns 2020 65.8% 2019 -0.5% 2018 -9.9% 2017 2.1% 2016 -14% 2015 27.1% 2014 56.8% 2013 26% 2012 37.1% Growth of 10k Over Years
Date Value 31 May 16 ₹10,000 31 May 17 ₹8,860 31 May 18 ₹8,234 31 May 19 ₹8,302 31 May 20 ₹10,469 31 May 21 ₹16,504 
Asset Allocation
Asset Class Value Cash 1.89% Equity 97.73% Debt 0.37% 
Sector Allocation
Sector Value Health Care 97.73% 
Top Securities Holdings / Portfolio
Holdings/Securities
Name Global Industry Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMADrug Manufacturers - Specialty & Generic 10% ₹177 Cr 2,700,000
↓ -100,000 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 20 | 500124Drug Manufacturers - Specialty & Generic 10% ₹170 Cr 330,000
↓ -20,000 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 30 Apr 20 | AUROPHARMADrug Manufacturers - Specialty & Generic 9% ₹165 Cr 1,680,000
↑ 80,000 Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | 500087Drug Manufacturers - General 9% ₹164 Cr 1,800,000 Lupin Ltd (Healthcare)
Equity, Since 31 Jul 18 | 500257Drug Manufacturers - Specialty & Generic 9% ₹150 Cr 1,400,000
↓ -100,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLABDrug Manufacturers - Specialty & Generic 8% ₹146 Cr 360,000 Strides Pharma Science Ltd (Healthcare)
Equity, Since 31 Mar 14 | STARDrug Manufacturers - Specialty & Generic 4% ₹65 Cr 750,000 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | 543220Medical Care Facilities 4% ₹61 Cr 2,700,000
↑ 399,966 Narayana Hrudayalaya Ltd (Healthcare)
Equity, Since 31 Dec 19 | NHMedical Care Facilities 3% ₹61 Cr 1,500,000
↓ -100,000 Cadila Healthcare Ltd (Healthcare)
Equity, Since 30 Apr 21 | 532321Drug Manufacturers - Specialty & Generic 3% ₹57 Cr 1,000,000
↑ 1,000,000
Talk to our investment specialistFund Managers
Name Since Tenure Tanmaya Desai 1 Jun 11 9.92 Yr. Custodians
Company Address Bank of Nova Scotia 12/13, Maker Chamber VI,220, Nariman Point HDFC Bank Ltd HDFC Bank House,Kamala Mills Compound,Senapati Bapat Marg,,Lower Parel (W), SBI-SG Global Securities Services Private Limited “B Wing”, “Jeevan Seva” Annexe Bldg.,Ground Floor, S.V. Road,Santacruz (W),,Mumbai – 400054 Registrar & Transfer Agent
Computer Age Management Services Ltd Address New No.10, Old No.178,,Kodambakkam High Road,,Opp. Hotel Palmgrove,,Nungambakkam FAX 91-44-28283610 Email enq_L@camsonline.com Administrator Companies
Company Address SBI Mutual Fund 191"E", Maker Tower,Cuffe Parade Auditors
Company Address M/s. M. M. Nissim & Co. 3rdFloor, B Wing, Barodawala Mansion, 81,,Dr. Annie Besant Road, Worli, All Plan & Options
Fund and Plan NAV 6 Month 1 Year 3 Year 5 Year SBI Healthcare Opportunities Fund
Growth ₹223.825
↓ -0.87 15.11 % 53.4 % 23.99 % 10.97 % SBI Healthcare Opportunities Fund
Normal Dividend, Payout ₹140.998
↓ -0.55 15.11 % 53.4 % 24 % 10.98 % SBI Healthcare Opportunities Fund
Normal Dividend, Reinvestment ₹140.998
↓ -0.55 15.11 % 53.4 % 24 % 10.98 % Data as on 18 Jun 21
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data.
AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153
Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.
©2021 Shepard Technologies Private Limited. All Rights Reserved